You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Tamoxifen reduced breast cancer risk but increased risks of thromboembolic events and all cause mortality in women

https://doi.org/10.1136/ebm.8.4.110

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Sources of funding: Cancer Research UK, and National Health and Medical Research Council Australia.

    • For correspondence: Professor J Cuzick, IBIS Trials Centre, London, UK. Jack.Cuzick{at}cancer.org.uk

    • ↵* See glossary.

    • ↵† Information provided by author.